Ann: Delivery of Further Positive Oxycodone Patch, page-3

re: Ann: Delivery of Further Positive Oxycodo... Love this comment from their advisor who used to be a division director at FDA:

Phosphagenics’ top-level regulatory advisors have responded favourably to the trial results. Our senior advisor, Lee S Simon MD, a former Division Director of Analgesic, Anti-inflammatory and Ophthalmologic Drug Products (DAAODP) at the FDA commented: “The delivery profile from this patch is extremely interesting and points to the need to engage with the FDA as soon as is practically possible. These results indicate that Phosphagenics is well on the way to creating a unique product.”